FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894846477> ?p ?o ?g. }

• W2894846477 endingPage "156" @default.
• W2894846477 startingPage "149" @default.
• W2894846477 abstract "Dolutegravir combined with darunavir/cobicistat is a promising NRTI-sparing and/or salvage strategy for the treatment of HIV-1 infection.This Phase I, open-label, 57 day, crossover, pharmacokinetic (PK) study, enrolled healthy volunteers aged 18-65 years, who were randomized to one of two groups. Group 1 received dolutegravir (50 mg) once daily for 14 days followed by a 7 day washout, then a 14 day dolutegravir/darunavir/cobicistat (DTG/DRV/COBI) once-daily co-administration period followed by a 7 day washout and finally a 14 day period of darunavir/cobicistat (800/150 mg) once daily. Group 2 followed the same sequence starting with darunavir/cobicistat and concluding with dolutegravir. Each group underwent intensive PK sampling over 24 h on day 14 of each drug period and DTG/DRV/COBI concentrations were measured using validated LC-MS/MS methods.Twenty participants completed all PK phases. Thirteen were female and median age and BMI were 33.5 years and 27 kg/m2. Dolutegravir geometric mean ratios (GMR, DTG/DRV/COBI versus dolutegravir alone) and 90% CI for Cmax, AUC0-24 and C24 were 1.01 (0.92-1.11), 0.95 (0.87-1.04) and 0.9 (0.8-1.0), respectively. Darunavir GMR (DRV/COBI/DTG versus darunavir/cobicistat alone) and 90% CI for Cmax, AUC0-24 and C24 were 0.90 (0.83-0.98), 0.93 (0.86-1.00) and 0.93 (0.78-1.11), respectively. No grade 3 or 4 adverse events or laboratory abnormalities were observed.Concentrations of dolutegravir and darunavir, when boosted with cobicistat, decreased by <10% during co-administration, suggesting this combination can be prescribed safely in the treatment of HIV-1, with no adjustment to current guideline-recommended dosages." @default.
• W2894846477 created "2018-10-12" @default.
• W2894846477 creator A5007876312 @default.
• W2894846477 creator A5011969265 @default.
• W2894846477 creator A5022857046 @default.
• W2894846477 creator A5033399092 @default.
• W2894846477 creator A5041365930 @default.
• W2894846477 creator A5041869752 @default.
• W2894846477 creator A5066429649 @default.
• W2894846477 creator A5089793108 @default.
• W2894846477 creator A5091868272 @default.
• W2894846477 date "2018-10-01" @default.
• W2894846477 modified "2023-10-17" @default.
• W2894846477 title "Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers" @default.
• W2894846477 cites W1967347018 @default.
• W2894846477 cites W1977685796 @default.
• W2894846477 cites W1999220842 @default.
• W2894846477 cites W2010723413 @default.
• W2894846477 cites W2046399600 @default.
• W2894846477 cites W2053219480 @default.
• W2894846477 cites W2061400800 @default.
• W2894846477 cites W2085120686 @default.
• W2894846477 cites W2090157578 @default.
• W2894846477 cites W2099658521 @default.
• W2894846477 cites W2104161734 @default.
• W2894846477 cites W2133117185 @default.
• W2894846477 cites W2135955998 @default.
• W2894846477 cites W2139167304 @default.
• W2894846477 cites W2144255757 @default.
• W2894846477 cites W2151589354 @default.
• W2894846477 cites W2152696551 @default.
• W2894846477 cites W2152880150 @default.
• W2894846477 cites W2155792409 @default.
• W2894846477 cites W2156933277 @default.
• W2894846477 cites W2157791496 @default.
• W2894846477 cites W2260708985 @default.
• W2894846477 cites W2273406108 @default.
• W2894846477 cites W2294678755 @default.
• W2894846477 cites W2406931452 @default.
• W2894846477 cites W2410506747 @default.
• W2894846477 cites W2422955030 @default.
• W2894846477 cites W2522930641 @default.
• W2894846477 cites W2593285831 @default.
• W2894846477 cites W2600324759 @default.
• W2894846477 cites W2609668389 @default.
• W2894846477 cites W2613086869 @default.
• W2894846477 cites W2622470207 @default.
• W2894846477 cites W2738986080 @default.
• W2894846477 cites W2746270715 @default.
• W2894846477 cites W2754259986 @default.
• W2894846477 cites W2757413803 @default.
• W2894846477 cites W2771326660 @default.
• W2894846477 cites W2776856490 @default.
• W2894846477 cites W2781681713 @default.
• W2894846477 cites W2788591875 @default.
• W2894846477 cites W2789230216 @default.
• W2894846477 cites W2792833909 @default.
• W2894846477 doi "https://doi.org/10.1093/jac/dky384" @default.
• W2894846477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30778557" @default.
• W2894846477 hasPublicationYear "2018" @default.
• W2894846477 type Work @default.
• W2894846477 sameAs 2894846477 @default.
• W2894846477 citedByCount "7" @default.
• W2894846477 countsByYear W28948464772019 @default.
• W2894846477 countsByYear W28948464772021 @default.
• W2894846477 countsByYear W28948464772022 @default.
• W2894846477 countsByYear W28948464772023 @default.
• W2894846477 crossrefType "journal-article" @default.
• W2894846477 hasAuthorship W2894846477A5007876312 @default.
• W2894846477 hasAuthorship W2894846477A5011969265 @default.
• W2894846477 hasAuthorship W2894846477A5022857046 @default.
• W2894846477 hasAuthorship W2894846477A5033399092 @default.
• W2894846477 hasAuthorship W2894846477A5041365930 @default.
• W2894846477 hasAuthorship W2894846477A5041869752 @default.
• W2894846477 hasAuthorship W2894846477A5066429649 @default.
• W2894846477 hasAuthorship W2894846477A5089793108 @default.
• W2894846477 hasAuthorship W2894846477A5091868272 @default.
• W2894846477 hasBestOaLocation W28948464771 @default.
• W2894846477 hasConcept C112705442 @default.
• W2894846477 hasConcept C142462285 @default.
• W2894846477 hasConcept C142724271 @default.
• W2894846477 hasConcept C159047783 @default.
• W2894846477 hasConcept C204787440 @default.
• W2894846477 hasConcept C22979827 @default.
• W2894846477 hasConcept C27081682 @default.
• W2894846477 hasConcept C2779182219 @default.
• W2894846477 hasConcept C2779298103 @default.
• W2894846477 hasConcept C2779502633 @default.
• W2894846477 hasConcept C2780524789 @default.
• W2894846477 hasConcept C2993143319 @default.
• W2894846477 hasConcept C3013748606 @default.
• W2894846477 hasConcept C71924100 @default.
• W2894846477 hasConcept C87813604 @default.
• W2894846477 hasConcept C98274493 @default.
• W2894846477 hasConceptScore W2894846477C112705442 @default.
• W2894846477 hasConceptScore W2894846477C142462285 @default.
• W2894846477 hasConceptScore W2894846477C142724271 @default.
• W2894846477 hasConceptScore W2894846477C159047783 @default.

• next